Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Cancer therapy). Showing records 1 – 30 of 1463 total matches.

[1] [2] [3] [4] [5] … [49]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


University of Southern California

1. Sankaranarayanan, Ishwarya. Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy.

Degree: MS, Molecular Microbiology and Immunology, 2014, University of Southern California

 B7‐H4 is a member of the B7 family, which is a costimulatory molecule and negatively regulates the immune response of T cells. Its mechanism of… (more)

Subjects/Keywords: cancer therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sankaranarayanan, I. (2014). Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/444516/rec/6030

Chicago Manual of Style (16th Edition):

Sankaranarayanan, Ishwarya. “Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy.” 2014. Masters Thesis, University of Southern California. Accessed January 16, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/444516/rec/6030.

MLA Handbook (7th Edition):

Sankaranarayanan, Ishwarya. “Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy.” 2014. Web. 16 Jan 2021.

Vancouver:

Sankaranarayanan I. Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy. [Internet] [Masters thesis]. University of Southern California; 2014. [cited 2021 Jan 16]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/444516/rec/6030.

Council of Science Editors:

Sankaranarayanan I. Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy. [Masters Thesis]. University of Southern California; 2014. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/444516/rec/6030


University of Otago

2. Mazumder, Aloran. Raloxifene along with curcumin analogue RL91, a combinational approach against hormone refractory prostate cancer .

Degree: 2013, University of Otago

 Background: Approximately 80% of prostate cancer patients undergoing hormone therapy progress within 12-18 months to a hormone insensitive form of the disease known as hormone… (more)

Subjects/Keywords: Therapy against prostate cancer; therapy; prostate; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mazumder, A. (2013). Raloxifene along with curcumin analogue RL91, a combinational approach against hormone refractory prostate cancer . (Masters Thesis). University of Otago. Retrieved from http://hdl.handle.net/10523/4070

Chicago Manual of Style (16th Edition):

Mazumder, Aloran. “Raloxifene along with curcumin analogue RL91, a combinational approach against hormone refractory prostate cancer .” 2013. Masters Thesis, University of Otago. Accessed January 16, 2021. http://hdl.handle.net/10523/4070.

MLA Handbook (7th Edition):

Mazumder, Aloran. “Raloxifene along with curcumin analogue RL91, a combinational approach against hormone refractory prostate cancer .” 2013. Web. 16 Jan 2021.

Vancouver:

Mazumder A. Raloxifene along with curcumin analogue RL91, a combinational approach against hormone refractory prostate cancer . [Internet] [Masters thesis]. University of Otago; 2013. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10523/4070.

Council of Science Editors:

Mazumder A. Raloxifene along with curcumin analogue RL91, a combinational approach against hormone refractory prostate cancer . [Masters Thesis]. University of Otago; 2013. Available from: http://hdl.handle.net/10523/4070


Deakin University

3. Ajji, Parminder Kaur. Functional characterization of a novel ribosome inactivating protein from Momordica balsamina.

Degree: School of Life and Environmental Sciences, 2016, Deakin University

 This study provides an insight into the cytotoxic potential of natural and recombinant ribosome-inactivating protein (Balsamin) from Momordica balsamina. It explores the molecular mechanism of… (more)

Subjects/Keywords: liver cancer therapy; breast cancer therapy; balsamin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ajji, P. K. (2016). Functional characterization of a novel ribosome inactivating protein from Momordica balsamina. (Thesis). Deakin University. Retrieved from http://hdl.handle.net/10536/DRO/DU:30103049

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ajji, Parminder Kaur. “Functional characterization of a novel ribosome inactivating protein from Momordica balsamina.” 2016. Thesis, Deakin University. Accessed January 16, 2021. http://hdl.handle.net/10536/DRO/DU:30103049.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ajji, Parminder Kaur. “Functional characterization of a novel ribosome inactivating protein from Momordica balsamina.” 2016. Web. 16 Jan 2021.

Vancouver:

Ajji PK. Functional characterization of a novel ribosome inactivating protein from Momordica balsamina. [Internet] [Thesis]. Deakin University; 2016. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10536/DRO/DU:30103049.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ajji PK. Functional characterization of a novel ribosome inactivating protein from Momordica balsamina. [Thesis]. Deakin University; 2016. Available from: http://hdl.handle.net/10536/DRO/DU:30103049

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Rutgers University

4. FENG, XING, 1987-. Roles of SETD4 in radiation sensitivity and tumorigenesis.

Degree: PhD, Pharmacology, Cellular and Molecular, 2018, Rutgers University

The SET domain protein methyltransferases play a critical role in histone modifications and global epigenetic regulations. Recent evidence suggests that some SET domain proteins may… (more)

Subjects/Keywords: Cancer – Gene therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

FENG, XING, 1. (2018). Roles of SETD4 in radiation sensitivity and tumorigenesis. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/59084/

Chicago Manual of Style (16th Edition):

FENG, XING, 1987-. “Roles of SETD4 in radiation sensitivity and tumorigenesis.” 2018. Doctoral Dissertation, Rutgers University. Accessed January 16, 2021. https://rucore.libraries.rutgers.edu/rutgers-lib/59084/.

MLA Handbook (7th Edition):

FENG, XING, 1987-. “Roles of SETD4 in radiation sensitivity and tumorigenesis.” 2018. Web. 16 Jan 2021.

Vancouver:

FENG, XING 1. Roles of SETD4 in radiation sensitivity and tumorigenesis. [Internet] [Doctoral dissertation]. Rutgers University; 2018. [cited 2021 Jan 16]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/59084/.

Council of Science Editors:

FENG, XING 1. Roles of SETD4 in radiation sensitivity and tumorigenesis. [Doctoral Dissertation]. Rutgers University; 2018. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/59084/

5. Wright, Robert Clay. ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY.

Degree: 2014, Johns Hopkins University

 Prevailing approaches for developing cancer protein therapeutics focus on creating proteins that therapeutically modulate a cancer marker’s function. Such an approach limits the therapeutic mechanism… (more)

Subjects/Keywords: Enzyme Prodrug Therapy; Protein Engineering; Cancer Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wright, R. C. (2014). ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37975

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wright, Robert Clay. “ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY.” 2014. Thesis, Johns Hopkins University. Accessed January 16, 2021. http://jhir.library.jhu.edu/handle/1774.2/37975.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wright, Robert Clay. “ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY.” 2014. Web. 16 Jan 2021.

Vancouver:

Wright RC. ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2021 Jan 16]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37975.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wright RC. ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37975

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Georgia Tech

6. Mackey, Megan A. Gold nanoparticles in some chemical and photothermal applications of cancer therapy.

Degree: PhD, Chemistry and Biochemistry, 2013, Georgia Tech

 Gold nanoparticles exhibit an array of properties, both intrinsic (chemical) and extrinsic (photothermal), that can be exploited for their use in cancer therapeutics. Owing to… (more)

Subjects/Keywords: Gold nanopartices; Cancer therapy; Photothermal therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mackey, M. A. (2013). Gold nanoparticles in some chemical and photothermal applications of cancer therapy. (Doctoral Dissertation). Georgia Tech. Retrieved from http://hdl.handle.net/1853/52934

Chicago Manual of Style (16th Edition):

Mackey, Megan A. “Gold nanoparticles in some chemical and photothermal applications of cancer therapy.” 2013. Doctoral Dissertation, Georgia Tech. Accessed January 16, 2021. http://hdl.handle.net/1853/52934.

MLA Handbook (7th Edition):

Mackey, Megan A. “Gold nanoparticles in some chemical and photothermal applications of cancer therapy.” 2013. Web. 16 Jan 2021.

Vancouver:

Mackey MA. Gold nanoparticles in some chemical and photothermal applications of cancer therapy. [Internet] [Doctoral dissertation]. Georgia Tech; 2013. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1853/52934.

Council of Science Editors:

Mackey MA. Gold nanoparticles in some chemical and photothermal applications of cancer therapy. [Doctoral Dissertation]. Georgia Tech; 2013. Available from: http://hdl.handle.net/1853/52934


Universiteit Utrecht

7. Tenhagen, M. FGFRs in breast cancer: expression, downstream effects and possible drug targets.

Degree: 2012, Universiteit Utrecht

 In the search of new drugs to treat cancer patients, many targeted therapies are being developed. Fibroblast growth factor receptors (FGFRs) are one of the… (more)

Subjects/Keywords: FGFR; breast cancer, targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tenhagen, M. (2012). FGFRs in breast cancer: expression, downstream effects and possible drug targets. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/220167

Chicago Manual of Style (16th Edition):

Tenhagen, M. “FGFRs in breast cancer: expression, downstream effects and possible drug targets.” 2012. Masters Thesis, Universiteit Utrecht. Accessed January 16, 2021. http://dspace.library.uu.nl:8080/handle/1874/220167.

MLA Handbook (7th Edition):

Tenhagen, M. “FGFRs in breast cancer: expression, downstream effects and possible drug targets.” 2012. Web. 16 Jan 2021.

Vancouver:

Tenhagen M. FGFRs in breast cancer: expression, downstream effects and possible drug targets. [Internet] [Masters thesis]. Universiteit Utrecht; 2012. [cited 2021 Jan 16]. Available from: http://dspace.library.uu.nl:8080/handle/1874/220167.

Council of Science Editors:

Tenhagen M. FGFRs in breast cancer: expression, downstream effects and possible drug targets. [Masters Thesis]. Universiteit Utrecht; 2012. Available from: http://dspace.library.uu.nl:8080/handle/1874/220167


University of Rochester

8. Stripay, Jennifer L. Targeting a Network of Cancer Control Nodes through Rescue of c-Cbl; A Novel Therapeutic Approach for Glioblastoma Multiforme.

Degree: PhD, 2016, University of Rochester

 Glioblastoma multiforme is the most common primary brain tumor in adults, the most malignant of all intracranial tumors, and is associated with inevitable recurrence and… (more)

Subjects/Keywords: Cancer; cbl; Glioblastoma; Redox; Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stripay, J. L. (2016). Targeting a Network of Cancer Control Nodes through Rescue of c-Cbl; A Novel Therapeutic Approach for Glioblastoma Multiforme. (Doctoral Dissertation). University of Rochester. Retrieved from http://hdl.handle.net/1802/31636

Chicago Manual of Style (16th Edition):

Stripay, Jennifer L. “Targeting a Network of Cancer Control Nodes through Rescue of c-Cbl; A Novel Therapeutic Approach for Glioblastoma Multiforme.” 2016. Doctoral Dissertation, University of Rochester. Accessed January 16, 2021. http://hdl.handle.net/1802/31636.

MLA Handbook (7th Edition):

Stripay, Jennifer L. “Targeting a Network of Cancer Control Nodes through Rescue of c-Cbl; A Novel Therapeutic Approach for Glioblastoma Multiforme.” 2016. Web. 16 Jan 2021.

Vancouver:

Stripay JL. Targeting a Network of Cancer Control Nodes through Rescue of c-Cbl; A Novel Therapeutic Approach for Glioblastoma Multiforme. [Internet] [Doctoral dissertation]. University of Rochester; 2016. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1802/31636.

Council of Science Editors:

Stripay JL. Targeting a Network of Cancer Control Nodes through Rescue of c-Cbl; A Novel Therapeutic Approach for Glioblastoma Multiforme. [Doctoral Dissertation]. University of Rochester; 2016. Available from: http://hdl.handle.net/1802/31636


University of Alberta

9. Keuling, Angela. Characterization of the response of melanoma cell lines to inhibition of anti-apoptotic Bcl-2 proteins.

Degree: PhD, Medical Sciences - Medical Genetics, 2010, University of Alberta

 Malignant melanoma is resistant to almost all conventional forms of chemotherapy. Recent evidence suggests that anti-apoptotic proteins of the Bcl-2 family are overexpressed in melanoma… (more)

Subjects/Keywords: apoptosis; cancer therapy; melanoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Keuling, A. (2010). Characterization of the response of melanoma cell lines to inhibition of anti-apoptotic Bcl-2 proteins. (Doctoral Dissertation). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/3t945r78j

Chicago Manual of Style (16th Edition):

Keuling, Angela. “Characterization of the response of melanoma cell lines to inhibition of anti-apoptotic Bcl-2 proteins.” 2010. Doctoral Dissertation, University of Alberta. Accessed January 16, 2021. https://era.library.ualberta.ca/files/3t945r78j.

MLA Handbook (7th Edition):

Keuling, Angela. “Characterization of the response of melanoma cell lines to inhibition of anti-apoptotic Bcl-2 proteins.” 2010. Web. 16 Jan 2021.

Vancouver:

Keuling A. Characterization of the response of melanoma cell lines to inhibition of anti-apoptotic Bcl-2 proteins. [Internet] [Doctoral dissertation]. University of Alberta; 2010. [cited 2021 Jan 16]. Available from: https://era.library.ualberta.ca/files/3t945r78j.

Council of Science Editors:

Keuling A. Characterization of the response of melanoma cell lines to inhibition of anti-apoptotic Bcl-2 proteins. [Doctoral Dissertation]. University of Alberta; 2010. Available from: https://era.library.ualberta.ca/files/3t945r78j

10. Walker, David. CREDENTIALING THE DNA METHYLATION MAINTENANCE PROTEIN UHRF1 AS A TARGET FOR ANTICANCER THERAPY.

Degree: 2014, Johns Hopkins University

Cancer is a disease of genome alterations that drive uncontrolled growth. The most challenging aspect of cancer treatment is that there are many avenues to… (more)

Subjects/Keywords: UHRF1; cancer; epigenetics; epigenetic therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Walker, D. (2014). CREDENTIALING THE DNA METHYLATION MAINTENANCE PROTEIN UHRF1 AS A TARGET FOR ANTICANCER THERAPY. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37192

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Walker, David. “CREDENTIALING THE DNA METHYLATION MAINTENANCE PROTEIN UHRF1 AS A TARGET FOR ANTICANCER THERAPY.” 2014. Thesis, Johns Hopkins University. Accessed January 16, 2021. http://jhir.library.jhu.edu/handle/1774.2/37192.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Walker, David. “CREDENTIALING THE DNA METHYLATION MAINTENANCE PROTEIN UHRF1 AS A TARGET FOR ANTICANCER THERAPY.” 2014. Web. 16 Jan 2021.

Vancouver:

Walker D. CREDENTIALING THE DNA METHYLATION MAINTENANCE PROTEIN UHRF1 AS A TARGET FOR ANTICANCER THERAPY. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2021 Jan 16]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37192.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Walker D. CREDENTIALING THE DNA METHYLATION MAINTENANCE PROTEIN UHRF1 AS A TARGET FOR ANTICANCER THERAPY. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37192

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vanderbilt University

11. Meador, Catherine Belle. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.

Degree: PhD, Cancer Biology, 2015, Vanderbilt University

 EGFR-mutant lung cancers are highly sensitive to EGFR tyrosine kinase inhibitors (TKIs; erlotinib/gefitinib/afatinib), but tumors develop drug resistance within 9-16 months. Resistance to gefitinib/erlotinib commonly… (more)

Subjects/Keywords: targeted therapy; EGFR; lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meador, C. B. (2015). Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/13334

Chicago Manual of Style (16th Edition):

Meador, Catherine Belle. “Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.” 2015. Doctoral Dissertation, Vanderbilt University. Accessed January 16, 2021. http://hdl.handle.net/1803/13334.

MLA Handbook (7th Edition):

Meador, Catherine Belle. “Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.” 2015. Web. 16 Jan 2021.

Vancouver:

Meador CB. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. [Internet] [Doctoral dissertation]. Vanderbilt University; 2015. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1803/13334.

Council of Science Editors:

Meador CB. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. [Doctoral Dissertation]. Vanderbilt University; 2015. Available from: http://hdl.handle.net/1803/13334


Penn State University

12. Yao, Nengliang. Radiation Therapy For Early Stage Breast Cancer After Breast-conserving Surgery.

Degree: 2013, Penn State University

 Background: Whole breast irradiation (WBI) has been recommended after breast-conserving surgery (BCS) in practice guidelines for definitive local therapy of early stage breast cancers since… (more)

Subjects/Keywords: Radiation Therapy; Breast Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yao, N. (2013). Radiation Therapy For Early Stage Breast Cancer After Breast-conserving Surgery. (Thesis). Penn State University. Retrieved from https://submit-etda.libraries.psu.edu/catalog/17428

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Yao, Nengliang. “Radiation Therapy For Early Stage Breast Cancer After Breast-conserving Surgery.” 2013. Thesis, Penn State University. Accessed January 16, 2021. https://submit-etda.libraries.psu.edu/catalog/17428.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Yao, Nengliang. “Radiation Therapy For Early Stage Breast Cancer After Breast-conserving Surgery.” 2013. Web. 16 Jan 2021.

Vancouver:

Yao N. Radiation Therapy For Early Stage Breast Cancer After Breast-conserving Surgery. [Internet] [Thesis]. Penn State University; 2013. [cited 2021 Jan 16]. Available from: https://submit-etda.libraries.psu.edu/catalog/17428.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yao N. Radiation Therapy For Early Stage Breast Cancer After Breast-conserving Surgery. [Thesis]. Penn State University; 2013. Available from: https://submit-etda.libraries.psu.edu/catalog/17428

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

13. Berinstein, Elliot. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.

Degree: 2016, University of Toronto

The adoptive transfer of T lymphocytes expressing chimeric antigen receptors (CARs) has become a promising treatment for various cancers. CARs have been shown to redirect… (more)

Subjects/Keywords: Cancer; Gene Therapy; Immunotherapy; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Berinstein, E. (2016). The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/90143

Chicago Manual of Style (16th Edition):

Berinstein, Elliot. “The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.” 2016. Masters Thesis, University of Toronto. Accessed January 16, 2021. http://hdl.handle.net/1807/90143.

MLA Handbook (7th Edition):

Berinstein, Elliot. “The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.” 2016. Web. 16 Jan 2021.

Vancouver:

Berinstein E. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. [Internet] [Masters thesis]. University of Toronto; 2016. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1807/90143.

Council of Science Editors:

Berinstein E. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. [Masters Thesis]. University of Toronto; 2016. Available from: http://hdl.handle.net/1807/90143


Colorado State University

14. Nieset, Jessica Rae. Use of cone-beam computed tomography to characterize urinary bladder variations and optimize delivery of radiation therapy for canine bladder cancer.

Degree: PhD, Environmental and Radiological Health Sciences, 2011, Colorado State University

 Urinary bladder cancer is the most common cancer of the canine urinary tract, with transitional cell carcinoma (TCC) being the most commonly diagnosed tumor type.… (more)

Subjects/Keywords: canine bladder cancer; radiation therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nieset, J. R. (2011). Use of cone-beam computed tomography to characterize urinary bladder variations and optimize delivery of radiation therapy for canine bladder cancer. (Doctoral Dissertation). Colorado State University. Retrieved from http://hdl.handle.net/10217/46380

Chicago Manual of Style (16th Edition):

Nieset, Jessica Rae. “Use of cone-beam computed tomography to characterize urinary bladder variations and optimize delivery of radiation therapy for canine bladder cancer.” 2011. Doctoral Dissertation, Colorado State University. Accessed January 16, 2021. http://hdl.handle.net/10217/46380.

MLA Handbook (7th Edition):

Nieset, Jessica Rae. “Use of cone-beam computed tomography to characterize urinary bladder variations and optimize delivery of radiation therapy for canine bladder cancer.” 2011. Web. 16 Jan 2021.

Vancouver:

Nieset JR. Use of cone-beam computed tomography to characterize urinary bladder variations and optimize delivery of radiation therapy for canine bladder cancer. [Internet] [Doctoral dissertation]. Colorado State University; 2011. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10217/46380.

Council of Science Editors:

Nieset JR. Use of cone-beam computed tomography to characterize urinary bladder variations and optimize delivery of radiation therapy for canine bladder cancer. [Doctoral Dissertation]. Colorado State University; 2011. Available from: http://hdl.handle.net/10217/46380


University of Ottawa

15. Watson, Margaret. Characterizing a Novel Viral Sensitizer BI-D1870 .

Degree: 2019, University of Ottawa

 Oncolytic viruses (OVs) are an emerging cancer therapy that use an oncotropic virus to selectively infect and kill cancer cells, as well as stimulate long-lasting… (more)

Subjects/Keywords: Oncolytic virus; Cancer therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Watson, M. (2019). Characterizing a Novel Viral Sensitizer BI-D1870 . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/39364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Watson, Margaret. “Characterizing a Novel Viral Sensitizer BI-D1870 .” 2019. Thesis, University of Ottawa. Accessed January 16, 2021. http://hdl.handle.net/10393/39364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Watson, Margaret. “Characterizing a Novel Viral Sensitizer BI-D1870 .” 2019. Web. 16 Jan 2021.

Vancouver:

Watson M. Characterizing a Novel Viral Sensitizer BI-D1870 . [Internet] [Thesis]. University of Ottawa; 2019. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10393/39364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Watson M. Characterizing a Novel Viral Sensitizer BI-D1870 . [Thesis]. University of Ottawa; 2019. Available from: http://hdl.handle.net/10393/39364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université Catholique de Louvain

16. Barragan Montero, Ana Maria. Robust, accurate and patient-specific treatment planning for proton therapy.

Degree: 2017, Université Catholique de Louvain

The survival statistics for cancer patients treated with radiation therapy using photon beams show that many treatments fail due to poor tumour local control (TLC).… (more)

Subjects/Keywords: Proton therapy; Cancer treatment planning

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Barragan Montero, A. M. (2017). Robust, accurate and patient-specific treatment planning for proton therapy. (Thesis). Université Catholique de Louvain. Retrieved from http://hdl.handle.net/2078.1/189076

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Barragan Montero, Ana Maria. “Robust, accurate and patient-specific treatment planning for proton therapy.” 2017. Thesis, Université Catholique de Louvain. Accessed January 16, 2021. http://hdl.handle.net/2078.1/189076.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Barragan Montero, Ana Maria. “Robust, accurate and patient-specific treatment planning for proton therapy.” 2017. Web. 16 Jan 2021.

Vancouver:

Barragan Montero AM. Robust, accurate and patient-specific treatment planning for proton therapy. [Internet] [Thesis]. Université Catholique de Louvain; 2017. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/2078.1/189076.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Barragan Montero AM. Robust, accurate and patient-specific treatment planning for proton therapy. [Thesis]. Université Catholique de Louvain; 2017. Available from: http://hdl.handle.net/2078.1/189076

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Missouri – Columbia

17. Carroll, Valerie (Valerie Nicole). Development of a rhodium tetrathioether bombesin analogue and investigation of cyclic and acyclic ligand systems for 105Rh(III).

Degree: 2013, University of Missouri – Columbia

 Rhodium-105 is an attractive nuclide for radiotherapeutic applications due to its nuclear properties (566 keV β-, 319 keV [19%], 306 keV [5%]) and the kinetic… (more)

Subjects/Keywords: bifunctional chelate; radiopharmaceutical; cancer therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Carroll, V. (. N. (2013). Development of a rhodium tetrathioether bombesin analogue and investigation of cyclic and acyclic ligand systems for 105Rh(III). (Thesis). University of Missouri – Columbia. Retrieved from https://doi.org/10.32469/10355/37585

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Carroll, Valerie (Valerie Nicole). “Development of a rhodium tetrathioether bombesin analogue and investigation of cyclic and acyclic ligand systems for 105Rh(III).” 2013. Thesis, University of Missouri – Columbia. Accessed January 16, 2021. https://doi.org/10.32469/10355/37585.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Carroll, Valerie (Valerie Nicole). “Development of a rhodium tetrathioether bombesin analogue and investigation of cyclic and acyclic ligand systems for 105Rh(III).” 2013. Web. 16 Jan 2021.

Vancouver:

Carroll V(N. Development of a rhodium tetrathioether bombesin analogue and investigation of cyclic and acyclic ligand systems for 105Rh(III). [Internet] [Thesis]. University of Missouri – Columbia; 2013. [cited 2021 Jan 16]. Available from: https://doi.org/10.32469/10355/37585.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Carroll V(N. Development of a rhodium tetrathioether bombesin analogue and investigation of cyclic and acyclic ligand systems for 105Rh(III). [Thesis]. University of Missouri – Columbia; 2013. Available from: https://doi.org/10.32469/10355/37585

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Melbourne

18. Corona, Silvia Paola. Targeted therapeutics in colorectal cancer.

Degree: 2013, University of Melbourne

 Colon cancer still remains the third cause of cancer related death in the western countries. Molecular targeted drugs have revolutionized the approach to cancer therapy(more)

Subjects/Keywords: colon cancer therapy; targeted therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Corona, S. P. (2013). Targeted therapeutics in colorectal cancer. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/38615

Chicago Manual of Style (16th Edition):

Corona, Silvia Paola. “Targeted therapeutics in colorectal cancer.” 2013. Doctoral Dissertation, University of Melbourne. Accessed January 16, 2021. http://hdl.handle.net/11343/38615.

MLA Handbook (7th Edition):

Corona, Silvia Paola. “Targeted therapeutics in colorectal cancer.” 2013. Web. 16 Jan 2021.

Vancouver:

Corona SP. Targeted therapeutics in colorectal cancer. [Internet] [Doctoral dissertation]. University of Melbourne; 2013. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/11343/38615.

Council of Science Editors:

Corona SP. Targeted therapeutics in colorectal cancer. [Doctoral Dissertation]. University of Melbourne; 2013. Available from: http://hdl.handle.net/11343/38615

19. Servedio, Danielle Lauren. Cancer Patients' Perception of Body Image: A Visual Exploration.

Degree: MA, Marital and Family Therapy, 2012, Loyola Marymount University

  This study explored the impact and trauma that a cancer diagnosis and cancer treatment can have on a women’s image and experience of her… (more)

Subjects/Keywords: Cancer; Body Image; Art therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Servedio, D. L. (2012). Cancer Patients' Perception of Body Image: A Visual Exploration. (Masters Thesis). Loyola Marymount University. Retrieved from https://digitalcommons.lmu.edu/etd/111

Chicago Manual of Style (16th Edition):

Servedio, Danielle Lauren. “Cancer Patients' Perception of Body Image: A Visual Exploration.” 2012. Masters Thesis, Loyola Marymount University. Accessed January 16, 2021. https://digitalcommons.lmu.edu/etd/111.

MLA Handbook (7th Edition):

Servedio, Danielle Lauren. “Cancer Patients' Perception of Body Image: A Visual Exploration.” 2012. Web. 16 Jan 2021.

Vancouver:

Servedio DL. Cancer Patients' Perception of Body Image: A Visual Exploration. [Internet] [Masters thesis]. Loyola Marymount University; 2012. [cited 2021 Jan 16]. Available from: https://digitalcommons.lmu.edu/etd/111.

Council of Science Editors:

Servedio DL. Cancer Patients' Perception of Body Image: A Visual Exploration. [Masters Thesis]. Loyola Marymount University; 2012. Available from: https://digitalcommons.lmu.edu/etd/111


University of Waterloo

20. Zhang, Qinrong. A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment.

Degree: 2017, University of Waterloo

 Cisplatin is the first and most widely used platinum-based chemotherapy drug and is the cornerstone agent in treating a broad spectrum of cancers, including ovarian… (more)

Subjects/Keywords: Cancer; Combination Therapy; Cisplatin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, Q. (2017). A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment. (Thesis). University of Waterloo. Retrieved from http://hdl.handle.net/10012/11272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zhang, Qinrong. “A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment.” 2017. Thesis, University of Waterloo. Accessed January 16, 2021. http://hdl.handle.net/10012/11272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zhang, Qinrong. “A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment.” 2017. Web. 16 Jan 2021.

Vancouver:

Zhang Q. A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment. [Internet] [Thesis]. University of Waterloo; 2017. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10012/11272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zhang Q. A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment. [Thesis]. University of Waterloo; 2017. Available from: http://hdl.handle.net/10012/11272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Texas

21. Mirza Nasiri, Nooshin Mirza. Novel Metal-Containing Nanoparticle Composites for Cancer Therapy and Imaging.

Degree: 2020, University of North Texas

 With all the improvements in cancer treatments, multidrug resistance is still the major challenge in treating cancer. Cells can develop multidrug resistance (MDR) during or… (more)

Subjects/Keywords: Nanoparticle; Cancer Therapy an Imaging

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mirza Nasiri, N. M. (2020). Novel Metal-Containing Nanoparticle Composites for Cancer Therapy and Imaging. (Thesis). University of North Texas. Retrieved from https://digital.library.unt.edu/ark:/67531/metadc1707253/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mirza Nasiri, Nooshin Mirza. “Novel Metal-Containing Nanoparticle Composites for Cancer Therapy and Imaging.” 2020. Thesis, University of North Texas. Accessed January 16, 2021. https://digital.library.unt.edu/ark:/67531/metadc1707253/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mirza Nasiri, Nooshin Mirza. “Novel Metal-Containing Nanoparticle Composites for Cancer Therapy and Imaging.” 2020. Web. 16 Jan 2021.

Vancouver:

Mirza Nasiri NM. Novel Metal-Containing Nanoparticle Composites for Cancer Therapy and Imaging. [Internet] [Thesis]. University of North Texas; 2020. [cited 2021 Jan 16]. Available from: https://digital.library.unt.edu/ark:/67531/metadc1707253/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mirza Nasiri NM. Novel Metal-Containing Nanoparticle Composites for Cancer Therapy and Imaging. [Thesis]. University of North Texas; 2020. Available from: https://digital.library.unt.edu/ark:/67531/metadc1707253/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

22. Zhao, Xianda. Regulation of Anti-Tumor Immunity and Immunotherapy Response In Colorectal Cancer.

Degree: PhD, Microbiology, Immunology and Cancer Biology, 2020, University of Minnesota

 Immune checkpoint blockade therapy (ICBT) has revolutionized the treatment and management of numerous cancers, yet a substantial proportion of colorectal cancer (CRC) patients are resistant.… (more)

Subjects/Keywords: Cancer; Colon; Immunology; Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhao, X. (2020). Regulation of Anti-Tumor Immunity and Immunotherapy Response In Colorectal Cancer. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/216112

Chicago Manual of Style (16th Edition):

Zhao, Xianda. “Regulation of Anti-Tumor Immunity and Immunotherapy Response In Colorectal Cancer.” 2020. Doctoral Dissertation, University of Minnesota. Accessed January 16, 2021. http://hdl.handle.net/11299/216112.

MLA Handbook (7th Edition):

Zhao, Xianda. “Regulation of Anti-Tumor Immunity and Immunotherapy Response In Colorectal Cancer.” 2020. Web. 16 Jan 2021.

Vancouver:

Zhao X. Regulation of Anti-Tumor Immunity and Immunotherapy Response In Colorectal Cancer. [Internet] [Doctoral dissertation]. University of Minnesota; 2020. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/11299/216112.

Council of Science Editors:

Zhao X. Regulation of Anti-Tumor Immunity and Immunotherapy Response In Colorectal Cancer. [Doctoral Dissertation]. University of Minnesota; 2020. Available from: http://hdl.handle.net/11299/216112


Rutgers University

23. Karjoo Diarkhan, Zahra, 1980-. Customization and optimization of a histone h2a-based vector for targeted gene transfer to cancer cells.

Degree: PhD, Pharmaceutical Science, 2015, Rutgers University

Developing an efficient and safe system for gene delivery is considered the bottleneck of gene therapy, where a successful delivery of the nucleic acid can… (more)

Subjects/Keywords: Gene therapy; Cancer – Treatment; Nanoparticles

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Karjoo Diarkhan, Zahra, 1. (2015). Customization and optimization of a histone h2a-based vector for targeted gene transfer to cancer cells. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/46367/

Chicago Manual of Style (16th Edition):

Karjoo Diarkhan, Zahra, 1980-. “Customization and optimization of a histone h2a-based vector for targeted gene transfer to cancer cells.” 2015. Doctoral Dissertation, Rutgers University. Accessed January 16, 2021. https://rucore.libraries.rutgers.edu/rutgers-lib/46367/.

MLA Handbook (7th Edition):

Karjoo Diarkhan, Zahra, 1980-. “Customization and optimization of a histone h2a-based vector for targeted gene transfer to cancer cells.” 2015. Web. 16 Jan 2021.

Vancouver:

Karjoo Diarkhan, Zahra 1. Customization and optimization of a histone h2a-based vector for targeted gene transfer to cancer cells. [Internet] [Doctoral dissertation]. Rutgers University; 2015. [cited 2021 Jan 16]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/46367/.

Council of Science Editors:

Karjoo Diarkhan, Zahra 1. Customization and optimization of a histone h2a-based vector for targeted gene transfer to cancer cells. [Doctoral Dissertation]. Rutgers University; 2015. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/46367/


Georgia State University

24. Yang, Lingyun. Design and Synthesis of Inhibitors of Hypoxia Inducible Factor-1-mediated Functions.

Degree: MS, Chemistry, 2017, Georgia State University

  Hypoxia Inducible Factors (HIFs) are very important transcription factors that can respond to low oxygen concentrations in the cellular environment. Inhibition of HIF’s transcriptional… (more)

Subjects/Keywords: hypoxia; hif-1; cancer therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yang, L. (2017). Design and Synthesis of Inhibitors of Hypoxia Inducible Factor-1-mediated Functions. (Thesis). Georgia State University. Retrieved from https://scholarworks.gsu.edu/chemistry_theses/104

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Yang, Lingyun. “Design and Synthesis of Inhibitors of Hypoxia Inducible Factor-1-mediated Functions.” 2017. Thesis, Georgia State University. Accessed January 16, 2021. https://scholarworks.gsu.edu/chemistry_theses/104.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Yang, Lingyun. “Design and Synthesis of Inhibitors of Hypoxia Inducible Factor-1-mediated Functions.” 2017. Web. 16 Jan 2021.

Vancouver:

Yang L. Design and Synthesis of Inhibitors of Hypoxia Inducible Factor-1-mediated Functions. [Internet] [Thesis]. Georgia State University; 2017. [cited 2021 Jan 16]. Available from: https://scholarworks.gsu.edu/chemistry_theses/104.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yang L. Design and Synthesis of Inhibitors of Hypoxia Inducible Factor-1-mediated Functions. [Thesis]. Georgia State University; 2017. Available from: https://scholarworks.gsu.edu/chemistry_theses/104

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New South Wales

25. Armstrong, Luke. Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic.

Degree: Biotechnology & Biomolecular Sciences, 2016, University of New South Wales

 Mesothelioma is a cancer of the pleural cavity in the lungs. The prognosis for people who develop this type of cancer is incredibly low, with… (more)

Subjects/Keywords: Cancer; Mesothelioma; EDV; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Armstrong, L. (2016). Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic. (Masters Thesis). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Armstrong, Luke. “Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic.” 2016. Masters Thesis, University of New South Wales. Accessed January 16, 2021. http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true.

MLA Handbook (7th Edition):

Armstrong, Luke. “Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic.” 2016. Web. 16 Jan 2021.

Vancouver:

Armstrong L. Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic. [Internet] [Masters thesis]. University of New South Wales; 2016. [cited 2021 Jan 16]. Available from: http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true.

Council of Science Editors:

Armstrong L. Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic. [Masters Thesis]. University of New South Wales; 2016. Available from: http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true


University of Texas – Austin

26. -7017-2332. Development of human enzymes for amino acid depletion therapy.

Degree: PhD, Cell and Molecular Biology, 2016, University of Texas – Austin

 Heterologous enzymes have been investigated for a variety of therapeutic purposes, including targeted enzymatic amino acid depletion for the treatment of a variety of cancers.… (more)

Subjects/Keywords: Human enzymes; Cancer therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

-7017-2332. (2016). Development of human enzymes for amino acid depletion therapy. (Doctoral Dissertation). University of Texas – Austin. Retrieved from http://dx.doi.org/10.26153/tsw/10061

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Chicago Manual of Style (16th Edition):

-7017-2332. “Development of human enzymes for amino acid depletion therapy.” 2016. Doctoral Dissertation, University of Texas – Austin. Accessed January 16, 2021. http://dx.doi.org/10.26153/tsw/10061.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

MLA Handbook (7th Edition):

-7017-2332. “Development of human enzymes for amino acid depletion therapy.” 2016. Web. 16 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Vancouver:

-7017-2332. Development of human enzymes for amino acid depletion therapy. [Internet] [Doctoral dissertation]. University of Texas – Austin; 2016. [cited 2021 Jan 16]. Available from: http://dx.doi.org/10.26153/tsw/10061.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Council of Science Editors:

-7017-2332. Development of human enzymes for amino acid depletion therapy. [Doctoral Dissertation]. University of Texas – Austin; 2016. Available from: http://dx.doi.org/10.26153/tsw/10061

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete


University of Melbourne

27. Au-Yeung, George. Cyclin E1 as a therapeutic target in high grade serous ovarian cancer.

Degree: 2017, University of Melbourne

 The central theme of this thesis is developing therapeutic strategies to selectively target CCNE1 amplified high grade serous ovarian cancer (HGSC). Patients with CCNE1 amplified… (more)

Subjects/Keywords: Ovarian cancer; Molecular targets; Cancer therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Au-Yeung, G. (2017). Cyclin E1 as a therapeutic target in high grade serous ovarian cancer. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/191772

Chicago Manual of Style (16th Edition):

Au-Yeung, George. “Cyclin E1 as a therapeutic target in high grade serous ovarian cancer.” 2017. Doctoral Dissertation, University of Melbourne. Accessed January 16, 2021. http://hdl.handle.net/11343/191772.

MLA Handbook (7th Edition):

Au-Yeung, George. “Cyclin E1 as a therapeutic target in high grade serous ovarian cancer.” 2017. Web. 16 Jan 2021.

Vancouver:

Au-Yeung G. Cyclin E1 as a therapeutic target in high grade serous ovarian cancer. [Internet] [Doctoral dissertation]. University of Melbourne; 2017. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/11343/191772.

Council of Science Editors:

Au-Yeung G. Cyclin E1 as a therapeutic target in high grade serous ovarian cancer. [Doctoral Dissertation]. University of Melbourne; 2017. Available from: http://hdl.handle.net/11343/191772


Rutgers University

28. Salman Noori, Faranak, 1986-. Stem cell-based ovarian cancer suicide gene therapy.

Degree: PhD, Pharmaceutical Science, 2015, Rutgers University

Cancer is a leading cause of death worldwide, resulting in 8.2 million deaths in 2012. Tumor suicide gene therapy is among the novel targeted therapeutics… (more)

Subjects/Keywords: Cancer – Gene therapy; Ovaries – Cancer; Stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Salman Noori, Faranak, 1. (2015). Stem cell-based ovarian cancer suicide gene therapy. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/48643/

Chicago Manual of Style (16th Edition):

Salman Noori, Faranak, 1986-. “Stem cell-based ovarian cancer suicide gene therapy.” 2015. Doctoral Dissertation, Rutgers University. Accessed January 16, 2021. https://rucore.libraries.rutgers.edu/rutgers-lib/48643/.

MLA Handbook (7th Edition):

Salman Noori, Faranak, 1986-. “Stem cell-based ovarian cancer suicide gene therapy.” 2015. Web. 16 Jan 2021.

Vancouver:

Salman Noori, Faranak 1. Stem cell-based ovarian cancer suicide gene therapy. [Internet] [Doctoral dissertation]. Rutgers University; 2015. [cited 2021 Jan 16]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/48643/.

Council of Science Editors:

Salman Noori, Faranak 1. Stem cell-based ovarian cancer suicide gene therapy. [Doctoral Dissertation]. Rutgers University; 2015. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/48643/


University College Cork

29. Sadadcharam, Mira. Expanding the use of electroporation from cutaneous to intraluminal and systemic applications.

Degree: 2015, University College Cork

Cancer is a global phenomenon transcending the boundaries of age, race, geography and socioeconomic background. As our understanding of cancer cell biology has improved, we… (more)

Subjects/Keywords: Electroporation; Electrochemotherapy; EndoVe; Cancer immunogene therapy; Immune therapy; Gene therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sadadcharam, M. (2015). Expanding the use of electroporation from cutaneous to intraluminal and systemic applications. (Thesis). University College Cork. Retrieved from http://hdl.handle.net/10468/3484

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sadadcharam, Mira. “Expanding the use of electroporation from cutaneous to intraluminal and systemic applications.” 2015. Thesis, University College Cork. Accessed January 16, 2021. http://hdl.handle.net/10468/3484.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sadadcharam, Mira. “Expanding the use of electroporation from cutaneous to intraluminal and systemic applications.” 2015. Web. 16 Jan 2021.

Vancouver:

Sadadcharam M. Expanding the use of electroporation from cutaneous to intraluminal and systemic applications. [Internet] [Thesis]. University College Cork; 2015. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10468/3484.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sadadcharam M. Expanding the use of electroporation from cutaneous to intraluminal and systemic applications. [Thesis]. University College Cork; 2015. Available from: http://hdl.handle.net/10468/3484

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Waterloo

30. Zargar, Bahram. A Synthetic Biology Approach to Bacteria Mediated Tumor Targeting.

Degree: 2014, University of Waterloo

 Development of a drug delivery agent that selectively targets and destroys tumor cells with minimal toxicity to normal tissues is a major challenge in cancer(more)

Subjects/Keywords: Synthetic Biology; Bacteria Mediated Cancer Therapy; Cancer; Clostridium Mediated Cancer Therapy; Quorum Sensing; S. aureus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zargar, B. (2014). A Synthetic Biology Approach to Bacteria Mediated Tumor Targeting. (Thesis). University of Waterloo. Retrieved from http://hdl.handle.net/10012/9014

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zargar, Bahram. “A Synthetic Biology Approach to Bacteria Mediated Tumor Targeting.” 2014. Thesis, University of Waterloo. Accessed January 16, 2021. http://hdl.handle.net/10012/9014.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zargar, Bahram. “A Synthetic Biology Approach to Bacteria Mediated Tumor Targeting.” 2014. Web. 16 Jan 2021.

Vancouver:

Zargar B. A Synthetic Biology Approach to Bacteria Mediated Tumor Targeting. [Internet] [Thesis]. University of Waterloo; 2014. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10012/9014.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zargar B. A Synthetic Biology Approach to Bacteria Mediated Tumor Targeting. [Thesis]. University of Waterloo; 2014. Available from: http://hdl.handle.net/10012/9014

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [49]

.